Low Disease Thresholds up to Three Years in Ixekizumab-Treated Patients with Psoriatic Arthritis in SPIRIT-P1 and SPIRIT-P2

Authors
Publication date
1 January 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    White Rose Research Online

    redirect
    oaioai:eprints.whiterose.ac.uk:17...
    Last time updated on 16/10/2021